UnknownPhase 2

Nepafenac Versus Ketorolac Eye Drops in Prevention of Intraoperative Miosis During Cataract Surgery

75 participantsStarted 2019-03-01

Plain-language summary

This study aim at determining the efficacy of Nepafenac and Ketorolac in obtaining adequate intraoperative mydriasis and preventing miosis during cataract surgery. It also compare the efficacy of both Nepafenac versus Ketorolac, and determine the more effective agent in preventing miosis during cataract surgery. The investigators try to determine if the effect of preoperative NSAIDs agents use would show a financial benefit, or this manoeuvre would add a financial load on the patients who are candidate for cataract surgery.

Who can participate

Age range2 Days – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with cataract who are candidate for cataract surgery Exclusion Criteria: * D.M, * Patient with other ocular comorbidities rather than cataract, * Patients with history of trauma. * Patients on Corticosteroid drops treatment. * Previous intraocular surgery.

What they're measuring

Prevention of miosis during cataract surgery

Timeframe: 30 minutes

Trial details

NCT IDNCT03851172

SponsorAssiut University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-12-01

View on ClinicalTrials.gov More Cataract trials